5 unknown, 1 active not recruiting, 1 completed. 5 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow EGFR-TK Inhibitor: new trials by email Literature Review of EGFR-TK Inhibitor trials Research Report on EGFR-TK Inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI EGFR-TK Inhibitor, Stereotactic radiotherapy - Brain Metastases, Non-small Cell Lung Cancer | Phase 2 | Active not recruiting | Fudan University | 202 | 2023-08-10 | 2025-09-15 |
| Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma EGFR-TK Inhibitor - Carcinoma, Adenoid Cystic | Phase 2 | Unknown | Qingdao Central Hospital | 20 | 2021-07-01 | 2023-03-29 |
| E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C EGFR-TK Inhibitor, EGF-PTI, Cyclophosphamide - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Completed | Instituto Oncológico Dr Rosell | 23 | 2018-07-06 | 2022-06-30 |
| Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer EGFR-TK Inhibitor, Anti-Angiogenic Drugs - Non Small Cell Lung Cancer | Phase 2 | Unknown | Xinqiao Hospital of Chongqing | 100 | 2018-05-01 | 2018-03-09 |
| IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer EGFR-TK Inhibitor, Intensity Modulated Radiation Therapy - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Not applicable | Unknown | LuBing | 160 | 2017-10-01 | 2017-08-25 |
| Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC EGFR-TK Inhibitor - Advanced Cancer, Lung Cancer, Nonsmall Cell | Phase 3 | Unknown | Zaiwen Fan | 80 | 2017-02-01 | 2017-01-04 |
| EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism EGFR-TK Inhibitor, EGFR-TKI, EGFR-TKI and Chemotherapy - Nonsmall Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 50 | 2016-12-01 | 2016-12-28 |
Carcinoma, Non-Small-Cell Lung (6) · Adenocarcinoma (1) · Brain Neoplasms (1) · Carcinoma, Adenoid Cystic (1) · Neoplasms, Glandular and Epithelial (1)
Fudan University (1) · Instituto Oncológico Dr Rosell (1) · LuBing (1) · Qingdao Central Hospital (1) · Shanghai Pulmonary Hospital, Shanghai, China (1) · Xinqiao Hospital of Chongqing (1) · Zaiwen Fan (1)
China (4) · Spain (1)
Anwen Liu (1) · Bing Lu (1) · Caicun Zhou, MD, PHD (1) · Chuangzhou Rao (1) · Dejun XIng (1) · Fang Liu (1) · Guang Han (1) · Guomei Tai (1) · Haihua Yang (1) · Hongqing Zhuang (1) · Hui Zhu (1) · Jiancheng Li (1) · Jichen Ren (1) · Jinjun Ye (1)
2017 (1)